GlucoTrack Inc (NASDAQ:GCTK)’s traded shares stood at 0.33 million during the last session, with the company’s beta value hitting -0.16. At the close of trading, the stock’s price was $0.25, to imply a decrease of -1.54% or -$0.01 in intraday trading. The GCTK share’s 52-week high remains $4.95, putting it -1880.0% down since that peak but still an impressive 12.0% since price per share fell to its 52-week low of $0.22. The company has a valuation of $1.47M, with an average of 0.49 million shares in intraday trading volume over the past 10 days and average of 372.05K shares over the past 3 months.

GlucoTrack Inc (NASDAQ:GCTK) trade information

After registering a -1.54% downside in the last session, GlucoTrack Inc (GCTK) has traded red over the past five days. The 5-day price performance for the stock is 5.07%, and -80.97% over 30 days. With these gigs, the year-to-date price performance is -80.50%. Short interest in GlucoTrack Inc (NASDAQ:GCTK) saw shorts transact 37921.0 shares and set a 6.03 days time to cover.

GCTK Dividends

GlucoTrack Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

GlucoTrack Inc (NASDAQ:GCTK)’s Major holders

GlucoTrack Inc insiders hold 34.98% of total outstanding shares, with institutional holders owning 0.95% of the shares at 1.47% float percentage. In total, 0.95% institutions holds shares in the company, led by ALERUS FINANCIAL NA.